INTRODUCTION
In response to anemia, erythropoietin (EPO) is expressed by interstitial kidney and fetal liver cells via hypoxia-inducible transcription factor pathways 1, 2 . As a secreted monomeric sialoglycoprotein, EPO then targets developing erythroblasts, and is essential for red cell formation during definitive bone marrow and fetal liver erythropoiesis [3] [4] [5] [6] [7] [8] . Prospective roles for EPO in promoting primitive red cell formation in yolk sac also have recently been described 9 . Beyond this, recombinant EPO has been demonstrated in ischemia and other cell damage models to provide cytoprotective effects for injured renal, cardiac, retinal and neuronal tissues 10, 11 . Taken together, these considerations have heightened interest in the specific nature of key EPO action mechanisms, especially those associated with progenitor cell survival.
EPO's prime effects are mediated via interactions with its dimeric single-transmembrane receptor (EPOR) [3] [4] [5] [6] [7] [8] 12 . These interactions appear to evoke EPOR conformational events 13 which are relayed to an upstream Janus kinase, JAK2 14 , (and JAK2 likewise may pre-assemble with EPOR dimers at a juxtamembrane box1 domain) 15, 16 . JAK2 as activated via a Y1007 phosphorylation loop 17 next stimulates two separable signal transduction pathways. First, JAK2 interestingly can support steadystate erythropoiesis via EPOR PY-independent routes which, in part, may involve MEK1,2 and ERK1,2 stimulation 18 . Second, JAK2 also mediates the phosphorylation of eight conserved EPOR cytoplasmic PY sites, which can then form a scaffold for the binding of up to twenty SH2-or PTBdomain encoding signal transduction factors and molecular adaptors [6] [7] [8] [19] [20] [21] .
Among conserved EPOR cytoplasmic PY sites, two appear to act predominately to engage pathways to progenitor cell survival. First, EPOR PY479 is a key binding site for p85-alpha, and the corecruitment of PI3 kinase's p110 catalytic subunit 22 . PI3 kinase's anti-apoptotic actions also involve AKT activation, and AKT's subsequent effects on mTOR, GSK3, and FOXO transcription factors [23] [24] [25] [26] .
In keeping with this notion, PI3-kinase inhibitors have been shown to attenuate the development of only.
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pos progenitor-derived primary human erythroblasts ex vivo 27 . Ectopic expression of a constitutively active AKT mutant in transduced murine Jak2 -/-fetal erythroblasts also can at least partially compensate for JAK2 deficiency 26 . Second, an EPOR proximal PY343 site which selectively recruits STAT5 18, 28 has been argued in cell line models to mediate Bcl-x gene expression 29 . BCL-XL itself is known to be expressed at high-levels in late-stage erythroblasts, and conditional disruption of the Bcl-x gene leads to cell death at a late erythroblast stage 30, 31 . Proposed EPO-dependent routes to Bcl-x modulation, however, remain a matter of some controversy 32 .
To advance an understanding of key EPO-regulated survival pathways, we presently have employed global transcriptome analyses to identify EPO-modulated (anti-)apoptotic factors in developmentally staged bone marrow derived erythroblasts. To define EPOR subdomains which might regulate distinct subsets of survival genes, such investigations further were extended to primary erythroblasts expressing minimal PY-null EPOR-HM and PY343-containing EPOR-H alleles. Studies overall reveal that EPO modulates the expression of eight (anti)apoptotic genes. Four factors previously associated with PI3K and/or AKT kinase pathways were EPO regulated: The signal transduction docking factor Irs2 33, 34 , the forkhead transcription factor FoxO3a 24, 25 and two pseudokinases Trb3 and Trb2 35, 36 . By comparison, only one Bcl2 family gene was EPO-modulated, Bim, a pro-apoptotic BH3-only factor 37, 38 . Two anti-apoptotic S/T kinases also were up-modulated, Pim1 and Pim3 39 , as was an atypical serpin protease inhibitor, Serpina3G 40, 41 . Notably, efficient EPO up-modulation of each survivalreinforcing factor proved to depend upon an intact EPOR-PY343 (and STAT5) signaling axis, an axis which can play key roles during anemia 42, 43 . In contrast, down-modulation of Bim, Fox03a and Trb2 was mediated via an EPOR PY-independent "JAK2-only" axis. Finally, both TRB3 and SERPINA-3G
were discovered through functional analyses to significantly protect erythroid progenitor cells from apoptosis due to EPO withdrawal. The nature, and possible action mechanism of these new EPOregulated survival factors are discussed further in the context of a new mechanistic model for proerythroblast survival.
only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From
MATERIALS AND METHODS

Mouse models and primary erythroblast preparations:
Mice expressing knocked-in EPOR-H and EPOR-HM alleles (and congenic controls) were as described 18, 42 µ g/mL amphotericin B (1XPSF) (Invitrogen) and 1.5 mM L-glutamine (i.e., "SP34-EX" medium) 45 . At 24 hours, 4 mL of fresh medium was added. At 48 hours, cells were collected, resuspended in 1 mL of conditioned medium, combined with 9 mL of fresh medium, and cultured for an additional 24 hours. 
Isolation of
RESULTS
Bone marrow erythroblast preparations, EPO survival responses, and transcriptome-based discovery of EPO-modulated (anti-)apoptotic genes
As a first step towards analyzing EPO survival responses in primary bone marrow-derived erythroblasts, a serum free expansion system was used to generate cohorts of erythroblasts at hours in the absence of hematopoietic cytokines (and in 50 µg/mL transferrin, 15 ng/mL insulin, 0.1 mM 2-mercaptoethanol, 0.5% BSA in IMDM). Cells then were exposed to EPO (+/-5 U/mL) for 90 minutes, and RNA was isolated. Biotin-cDNA was prepared, and was hybridized to Affymetrix 430-only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From 2.0 arrays. Target genes which were modulated >2-fold by EPO at a confidence level of >99% were identified via significance analysis of microarrays, Student's T-testing, and Array Assist algorithms.
Based on EPO's key role as an erythroblast survival factor, prime attention then was paid to EPOregulated anti-apoptotic factors.
Among greater than 1000 prospective (anti-)apoptotic transcripts represented on 430-2.0 assays, only eight proved to be significantly modulated by EPO ( Figure 1B Among Bcl2 related genes, only the pro-apoptotic BH3 domain factor Bim 37,38 proved to be EPOregulated, and was rapidly down-modulated several fold. Two PIM kinases, Pim1 and Pim3 39 , which act in parallel to AKT (and mTOR), however, were induced up to 5-fold by EPO. Finally, an atypical serpin (and putative protease inhibitor) 40, 41 which recently has been implicated in helper T-cell development 52 was observed to be strongly EPO-induced, Serpina-3G (S3G). For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From a time-course consistent with an immediate-early response ( Figure 2B ) (as indicated via direct comparison to an EPO-regulated immediate-early gene, Egr1 (data not shown). Second, the downmodulated transcripts Trb2, FoxO3a, and Bim1 were affected rapidly by EPO (i.e., within 30 minutes).
Analyses of EPO-regulated (anti-
Third, effects were both most prominent, and most sustained, for Trb3 and Serpina-3G as new candidate EPO-regulated survival factors.
Coupling of EPO-modulated transcriptional response circuits to EPO receptor functional subdomains
JAK2 is essential for erythropoiesis 13, 53 , and has been argued to be sufficient for EPOR-directed red cell formation 26, 54 . This notion is supported by the ability of mice expressing a PY-null EPOR-HM allele to support steady-state, but not stress erythropoiesis 42 . Stress erythropoiesis, in contrast, is efficiently rescued upon the restoration of a single EPOR PY343 STAT5 binding site 42, 43 . It therefore was of interest to investigate the extent to which EPOR coupling to modulated survival genes might depend upon, PY343, distal EPOR PY sites, or perhaps an EPOR juxta-membrane box-1 domain for JAK2 binding 15, 16 .
This was investigated using purified Kit Interestingly, this response (GAB2 PY452 phosphorylation) also was efficiently supported in EPOR-H, but not EPOR-HM pro-erythroblasts ( Figure 4A ). These analyses were consistent with a prior report of EPO-induced GAB2 phosphorylation 56 , and further link this pathway to STAT5 signals. In addition, and following EPO exposure, co-immunoprecipitation of phospho-GAB2 with STAT5 also could be demonstrated in wt-EPOR erythroblasts, (data not shown).
For GAB2, one prime binding partner is PI3-kinase 57 . EPOR PY343 mediated STAT5 engagement of GAB2 therefore was predicted to lead to PI3 kinase and ATK kinase activation. However, as shown in Figure 4B not only EPOR-HM but also EPOR-H erythroblasts proved to only inefficiently support EPO-dependent AKT activation ( Figure 4B ). As a correlate, EPO-dependent survival effects were analyzed directly (and in parallel) in wt-EPOR, EPOR-H and EPOR-HM pro-erythroblasts treated with the PI3K inhibitor LY294002 58 ( Figure 4C ). Outcomes demonstrated compromised survival for only.
For SERPINA-3G (S3G) next was studied, initially via western blot experiments. In wt-EPOR erythroblasts, EPO clearly induced S3G expression at increased levels ( Figure 6A-1 ). In both EPOR-H and EPOR-HM erythroblasts, however, S3G expression interestingly proved to be sustained upon only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From 13 EPO-withdrawal ( Figure 6A-2) . This outcome was unexpected, and suggests that S3G may be subject to significant post-transcriptional regulation (here, in a potentially compensatory mode for minimal EPOR alleles).
Next, EPO-dependent G1E/JC4 cells were implemented as a model for analyses of S3G action. This model was chosen based on a capacity of G1E/JC4 cells to also inducibly activate a GATA1-ER fusion protein, and terminally differentiate 59 . (Differentiation, however, did not prove to be affected by S3G, data not shown). G1E/JC4 cells were transduced with a MIGR-(flag)S3G retrovirus, and empty control vector, and GFP pos lines were isolated from two independent transductions. Possible effects of ectopically expressed S3G on survival then were assessed. Exponentially growing G1E/JC4-S3G
and control G1E/JC4-MIGR cells were cultured in the presence of EPO at limiting concentrations. At 18 hours of culture, frequencies of apoptotic cells were determined by staining with APC-annexin V, and via flow cytometry. S3G proved to significantly inhibit apoptosis as incurred due to EPO withdrawal ( Figure 6B and 6C ). This effect was observed reproducibly for separate sets of independently transduced G1E/JC4 cells, and in repeated analyses.
Because the majority of serpins are secreted 40, 41 , cell fractionation experiments also were performed to determine SERPINA-3G's subcellular localization. In these experiments, no detectable amounts of (flag)-SERPINA-3G were observed in concentrated conditioned media, or in nuclear extracts.
Instead, (flag)-SERPINA-3G appeared to be localized to a cytosolic compartment ( Figure 6D ).
Possible release from membrane compartments, however, presently cannot be discounted, and subcellular localization may not fully reflect that of endogenous S3G. Figure 7A ). These results therefore further underline the potential importance of alternate survival factors such as S3G and TRB3 as candidate mediators of EPO's anti-apoptotic effects. In Figure 7B , a model is outlined for presently defined EPO-regulated survival circuits in highly EPO-dependent early stage bone marrow erythroblasts.
Model for EPO-regulated survival circuits in primary Kit
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From DISCUSSION EPO is an essential factor for developing erythroblasts 3, 62 , and its prime actions are thought to affect progenitor cell survival 4, [6] [7] [8] . Consistent with this concept, EPO also has been demonstrated to exert cytoprotective effects in injured cardiac, renal, brain and retinal cells 10, 11 . In a distinct potential cancer cell context, EPO furthermore has been reported to increase mortality in patients with head and neck, and metastatic breast cancers 31, 63 . Together, these observations have heightened interest in better understanding EPO's specific response pathways. The present study focuses on EPO survival signals, and employs primary bone marrow erythroblasts plus global transcriptome analyses to define new candidate pathway components.
As one core point for discussion, survival circuits modulated via the PY-null allele EPOR-HM first are considered. Despite a conserved evolution among vertebrates 20, 64 , EPOR cytoplasmic PY binding motifs for SH2-and PTB domain signal transduction factors appear to be non-essential for steadystate (but not stress) erythropoiesis 18, 54 . Prior analyses of EPOR-HM signaling have ruled out the potential for compensatory engagement of at least certain EPOR-R PY-coupled signal transduction factors (e.g., STAT-5, -3, -1) 18, 42 . Coupling (via PI3K) to AKT also is decreased substantially for this allele (see Figure 4) . MEK1,2 and ERK1,2 signaling via EPOR-HM, in contrast, is sustained 18 .
Inhibition of this latter pathway, however, appears to selectively impact on differentiation rather than growth or survival potentials 18 . This raises questions as to how EPOR PY-independent JAK2-only signaling might inhibit programmed cell death. Pim1 is expressed at high levels in hematopoietic tissues 69 , and its disruption also leads to microcytic anemia 70 . Mechanistically, PIMs initially were indicated to act convergently with AKT pathways to regulate mTOR 39 . Genetic dissections, however, indicate separable yet parallel survival pathways 71 .
These considerations, together with recent evidence for STAT5 plus PIM kinase enforced leukemogenic events 72 further support a case that PIM1 and PIM3 likely comprise important EPO (and STAT5) response survival factors for EPO-dependent erythroblasts. For TRB3, its sustained expression was induced multi-fold by EPO and also depended upon EPOR/PY343/STAT signaling (see Figures 1-3 and 5) . Certain prior studies predicted that TRB3 might act in negative feedback loops including inhibitory effects on AKT 48 . Uncertainty exists, however, concerning TRB3's molecular action mechanisms 73 . In particular, TRB3 recently has been demonstrated to act as an E3
ubiquitin ligase coupling factor with COP1, and to target adipocyte acetyl co-enzyme A carboxylase for turnover 47 . To provide initial insight into EPO-related roles for TRB3, a lentiviral vector encoding TRB3 presently was prepared, and was used to stably transduce EPO-dependent erythroid progenitor cells. When EPO was limiting, TRB3 significantly enhanced survival (see Figure 5 ). Ways via which TRB3 acts within an EPO/EPOR signaling axis to inhibit cell death are presently uncertain. By speculation, this might involve TRB3 targeting of a key pro-apoptotic factor in developing only.
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For Serpina-3G (S3G), its induced expression likewise proved to depend sharply on EPOR/PY343/STAT5 signals, and was efficiently promoted in primary proerythroblasts by EPOR-H but not by EPOR-HM. Serpins typically are secreted protease inhibitors with broad-range biological functions. Within a hematopoietic growth factor context, one example involves GCSF inhibition of SERPINAs -1 and -3 74 within a stem cell niche. Specifically, GCSF repression of these secreted serpins relieves an inhibition of proteases which then act to promote CD34 cell release 74 . For SERPINA-3G, one rationale for considering possible cytoprotective roles is a recent case described for promoting helper T-cell expansion 52 . These studies of T-cells, however, did not involve a cytokine signaling context. Presently, ectopic expression of S3G in EPO-dependent erythroid progenitors is shown to protect against apoptosis due to cytokine withdrawal (see Figure 6C Two PI3 kinase pathway-associated docking factors, Irs2 and GAB2, also are presently shown to be regulated by EPO. For Irs2, activation was at the transcript level. EPO-induced S731 phosphorylation of IRS2, however, was not detected. GAB2, in contrast, proved to be regulated by only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From EPO at the level of S473 phosphorylation, and this furthermore depended sharply upon intactness of an EPOR PY343 STAT5 binding site. GAB2 also can couple to p85 and GRB2 34, 75 . This then provides routes for EPOR PY343 (and STAT5) coupling to AKT and ERK1/2 survival pathways.
Silencing of GAB2 plus STAT5 in fact, has recently been shown to inhibit BCR-ABL dependent survival of chronic myeloid leukemia cells 76 .
A final point for discussion concerns potential coupling of EPOR signals to BCL-XL expression. Via gene disruption experiments, Bcl-x has been shown to be essential for red cell development 31 . In addition, and in several cell line models, Bcl-x (and Bcl2) have been observed to be up-modulated by EPO 60, 61 . Bcl-x expression further has been argued to be induced by EPO via an EPOR/JAK2/PY343/STAT5 axis 29 . In the presently studied primary erythroblast system, however, EPO-modulation of BCL-x or BCL2 was not detectable at any significant levels. -actin as a normalizing control) . For an independent sample set, time-course analyses were repeated. Results are illustrated for two such analyses as mean fold-modulation due to EPO for each EPO-modulated candidate survival factor. 58 ,and were cultured in the presence of EPO at 0.2U/mL. At 18 hours of culture, frequencies of apoptotic cells were determined by Annexin V staining and flow cytometry.
Representative outcomes for LY274002 dosing at 15 and 50 micromolar are shown. only.
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